Correlation Between Aquestive Therapeutics and Cannara Biotech
Can any of the company-specific risk be diversified away by investing in both Aquestive Therapeutics and Cannara Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aquestive Therapeutics and Cannara Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aquestive Therapeutics and Cannara Biotech, you can compare the effects of market volatilities on Aquestive Therapeutics and Cannara Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aquestive Therapeutics with a short position of Cannara Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aquestive Therapeutics and Cannara Biotech.
Diversification Opportunities for Aquestive Therapeutics and Cannara Biotech
-0.17 | Correlation Coefficient |
Good diversification
The 3 months correlation between Aquestive and Cannara is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding Aquestive Therapeutics and Cannara Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cannara Biotech and Aquestive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aquestive Therapeutics are associated (or correlated) with Cannara Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cannara Biotech has no effect on the direction of Aquestive Therapeutics i.e., Aquestive Therapeutics and Cannara Biotech go up and down completely randomly.
Pair Corralation between Aquestive Therapeutics and Cannara Biotech
Given the investment horizon of 90 days Aquestive Therapeutics is expected to under-perform the Cannara Biotech. But the stock apears to be less risky and, when comparing its historical volatility, Aquestive Therapeutics is 1.35 times less risky than Cannara Biotech. The stock trades about -0.06 of its potential returns per unit of risk. The Cannara Biotech is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 53.00 in Cannara Biotech on September 1, 2024 and sell it today you would lose (2.00) from holding Cannara Biotech or give up 3.77% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Aquestive Therapeutics vs. Cannara Biotech
Performance |
| Timeline |
| Aquestive Therapeutics |
| Cannara Biotech |
Aquestive Therapeutics and Cannara Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aquestive Therapeutics and Cannara Biotech
The main advantage of trading using opposite Aquestive Therapeutics and Cannara Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aquestive Therapeutics position performs unexpectedly, Cannara Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cannara Biotech will offset losses from the drop in Cannara Biotech's long position.| Aquestive Therapeutics vs. Evoke Pharma | Aquestive Therapeutics vs. Dynavax Technologies | Aquestive Therapeutics vs. Amphastar P | Aquestive Therapeutics vs. Lantheus Holdings |
| Cannara Biotech vs. Benchmark Botanics | Cannara Biotech vs. Speakeasy Cannabis Club | Cannara Biotech vs. City View Green | Cannara Biotech vs. BC Craft Supply |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |